Installation of a Synchrotron Radiation Beamline Facility at the J. Bennett Johnston, Sr. Center for Advanced Microstructures and Devices for the Science and Engineering Alliance. Phase I and II. Final report of Grant DE FG 05-95ER45549 for September 15, 1995 to December 15, 1998.

2000 ◽  
Author(s):  
Robert Gooden
Keyword(s):  
Synchrotron Radiation ◽  
Phase I ◽  
Final Report ◽  
Science And Engineering ◽  
Phase I And Ii

scholarly journals SASS-ACA Phase I and II sodium testing. Final report

1984 ◽  
Author(s):  
Not Given Author
Keyword(s):  
Phase I ◽  
Final Report ◽  
Phase I And Ii

Zoledronic acid in cancer patients with bone metastases: Results of Phase I and II trials

2001 ◽  
Vol 28 (2C) ◽  
pp. 25-34 ◽  
Author(s):  
James R. Berenson
Keyword(s):  
Zoledronic Acid ◽  
Phase I ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Phase I And Ii

Review of the Carrier Approach Criteria for Carrier-Based Aircraft - Phase I: Final Report

2002 ◽  
Author(s):  
Thomas Rudowsky ◽  
Marshall Hynes ◽  
Melvin Luter ◽  
Robert Niewoehner ◽  
Page Senn
Keyword(s):  
Phase I ◽  
Final Report

Phase I and II Archaeological Investigations at Shaw Air Force Base and the Poinsett Electronic Combat Range, Sumter County, South Carolina

2005 ◽  
Author(s):  
Alvin J. Banguilan ◽  
John S. Cable ◽  
Charles E. Cantley ◽  
Leslie Raymer ◽  
Victoria Dabir-Banguilan
Keyword(s):  
South Carolina ◽  
Phase I ◽  
Air Force ◽  
Air Force Base ◽  
Phase I And Ii

scholarly journals Osteosarcoma Pathogenesis Leads the Way to New Target Treatments

2021 ◽  
Vol 22 (2) ◽  
pp. 813
Author(s):  
Isabel Fernandes ◽  
Cecília Melo-Alvim ◽  
Raquel Lopes-Brás ◽  
Miguel Esperança-Martins ◽  
Luís Costa
Keyword(s):  
Clinical Trials ◽  
Phase I ◽  
Poor Prognosis ◽  
Therapeutic Targets ◽  
Rare Condition ◽  
Basic Research ◽  
Metastatic Setting ◽  
Phase I And Ii ◽  
The Way

Osteosarcoma (OS) is a rare condition with very poor prognosis in a metastatic setting. Basic research has enabled a better understanding of OS pathogenesis and the discovery of new potential therapeutic targets. Phase I and II clinical trials are already ongoing, with some promising results for these patients. This article reviews OS pathogenesis and new potential therapeutic targets.

Sign in / Sign up

Export Citation Format

Share Document